Join
Live feed
·
PRReleasevia Quantisnow
Lisata Therapeutics Inc. logo

Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide

ByQuantisnow·Wall Street's wire, on your screen.
LSTA· Lisata Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LSTA (Lisata Therapeutics Inc.) and more on Quantisnow.